FULCRUM THERAPEUTICS, INC. Capital Expenditures
FULCRUM THERAPEUTICS, INC. (FULC) reported Capital Expenditures of $116.00 thousand for the 6-month period ending 2026-06-30, per its S-4 filed 2026-09-02.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-09-02
- FULCRUM THERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $108.00K, a 66.15% increase year-over-year.
- FULCRUM THERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $8.00K.
- FULCRUM THERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $159.00K, a 31.17% decline year-over-year.
- FULCRUM THERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $90.00K, a 373.68% increase year-over-year.
- FULCRUM THERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2023 was $508.00K, a 74.12% decline from fiscal 2022.
- FULCRUM THERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2022 was $1.96M, a 14.59% increase from fiscal 2021.
- FULCRUM THERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2021 was $1.71M, a 27.65% increase from fiscal 2020.
- FULCRUM THERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2020 was $1.34M, a 57.33% increase from fiscal 2019.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $108.00K derived: S-4 6 month − 10-Q 3 month · filed 2026-09-02 | $116.00K S-4 · filed 2026-09-02 | $275.00K derived: sum of 3 quarters · filed 2026-09-02 | $365.00K derived: sum of 4 quarters · filed 2026-09-02 |
| 2026-03-31 | $8.00K 10-Q · filed 2026-04-27 | $167.00K derived: sum of 2 quarters · filed 2026-09-02 | $257.00K derived: sum of 3 quarters · filed 2026-09-02 | $322.00K derived: sum of 4 quarters · filed 2026-09-02 |
| 2025-12-31 | $159.00K derived: S-4 12 month − 10-Q 9 month · filed 2026-09-02 | $249.00K derived: sum of 2 quarters · filed 2026-09-02 | $314.00K derived: sum of 3 quarters · filed 2026-09-02 | $314.00K S-4 · filed 2026-09-02 |
| 2025-09-30 | $90.00K derived: 10-Q 9 month − S-4 6 month · filed 2025-10-29 | $155.00K derived: sum of 2 quarters · filed 2026-09-02 | $155.00K 10-Q · filed 2025-10-29 | $386.00K derived: sum of 4 quarters · filed 2026-09-02 |
| 2025-06-30 | $65.00K derived: S-4 6 month − 10-Q 3 month · filed 2026-09-02 | $65.00K S-4 · filed 2026-09-02 | $296.00K derived: sum of 3 quarters · filed 2026-09-02 | $315.00K derived: sum of 4 quarters · filed 2026-09-02 |
| 2025-03-31 | $0.00 10-Q · filed 2026-04-27 | $231.00K derived: sum of 2 quarters · filed 2026-09-02 | $250.00K derived: sum of 3 quarters · filed 2026-09-02 | $250.00K derived: sum of 4 quarters · filed 2026-09-02 |
| 2024-12-31 | $231.00K derived: S-4 12 month − 10-Q 9 month · filed 2026-09-02 | $250.00K derived: sum of 2 quarters · filed 2026-09-02 | $250.00K derived: sum of 3 quarters · filed 2026-09-02 | $278.00K S-4 · filed 2026-09-02 |
| 2024-09-30 | $19.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $19.00K derived: sum of 2 quarters · filed 2025-10-29 | $47.00K 10-Q · filed 2025-10-29 | $124.00K derived: sum of 4 quarters · filed 2025-10-29 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $28.00K 10-Q · filed 2025-07-29 | $105.00K derived: sum of 3 quarters · filed 2025-07-29 | $170.00K derived: sum of 4 quarters · filed 2025-07-29 |
| 2024-03-31 | $28.00K 10-Q · filed 2025-05-01 | $105.00K derived: sum of 2 quarters · filed 2025-05-01 | $170.00K derived: sum of 3 quarters · filed 2025-05-01 | $365.00K derived: sum of 4 quarters · filed 2025-05-01 |
| 2023-12-31 | $77.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $142.00K derived: sum of 2 quarters · filed 2025-02-25 | $337.00K derived: sum of 3 quarters · filed 2025-02-25 | $508.00K 10-K · filed 2025-02-25 |
| 2023-09-30 | $65.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $260.00K derived: sum of 2 quarters · filed 2024-11-13 | $431.00K 10-Q · filed 2024-11-13 | $547.00K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $195.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $366.00K 10-Q · filed 2024-07-31 | $482.00K derived: sum of 3 quarters · filed 2024-07-31 | $765.00K derived: sum of 4 quarters · filed 2024-07-31 |
| 2023-03-31 | $171.00K 10-Q · filed 2024-05-13 | $287.00K derived: sum of 2 quarters · filed 2024-05-13 | $570.00K derived: sum of 3 quarters · filed 2024-05-13 | $1.89M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $116.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $399.00K derived: sum of 2 quarters · filed 2024-02-27 | $1.72M derived: sum of 3 quarters · filed 2024-02-27 | $1.96M 10-K · filed 2024-02-27 |
| 2022-09-30 | $283.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $1.60M derived: sum of 2 quarters · filed 2023-11-07 | $1.85M 10-Q · filed 2023-11-07 | $2.37M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $1.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $1.56M 10-Q · filed 2023-08-03 | $2.08M derived: sum of 3 quarters · filed 2023-08-03 | $2.45M derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | $246.00K 10-Q · filed 2023-05-15 | $765.00K derived: sum of 2 quarters · filed 2023-06-26 | $1.13M derived: sum of 3 quarters · filed 2023-06-26 | $1.70M derived: sum of 4 quarters · filed 2023-06-26 |
| 2021-12-31 | $519.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-06-26 | $886.00K derived: sum of 2 quarters · filed 2023-06-26 | $1.45M derived: sum of 3 quarters · filed 2023-06-26 | $1.71M 10-K/A · filed 2023-06-26 |
| 2021-09-30 | $367.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $932.00K derived: sum of 2 quarters · filed 2022-11-08 | $1.19M 10-Q · filed 2022-11-08 | $1.67M derived: sum of 4 quarters · filed 2023-06-26 |
| 2021-06-30 | $565.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $827.00K 10-Q · filed 2022-08-11 | $1.30M derived: sum of 3 quarters · filed 2023-06-26 | $1.39M derived: sum of 4 quarters · filed 2023-06-26 |
| 2021-03-31 | $262.00K 10-Q · filed 2022-05-09 | $734.00K derived: sum of 2 quarters · filed 2023-06-26 | $827.00K derived: sum of 3 quarters · filed 2023-06-26 | $1.04M derived: sum of 4 quarters · filed 2023-06-26 |
| 2020-12-31 | $472.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-06-26 | $565.00K derived: sum of 2 quarters · filed 2023-06-26 | $775.00K derived: sum of 3 quarters · filed 2023-06-26 | $1.34M 10-K/A · filed 2023-06-26 |
| 2020-09-30 | $93.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $303.00K derived: sum of 2 quarters · filed 2021-11-04 | $870.00K 10-Q · filed 2021-11-04 | $978.00K derived: sum of 4 quarters · filed 2023-06-23 |
| 2020-06-30 | $210.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $777.00K 10-Q · filed 2021-08-10 | $885.00K derived: sum of 3 quarters · filed 2023-06-23 | $1.10M derived: sum of 4 quarters · filed 2023-06-23 |
| 2020-03-31 | $567.00K 10-Q · filed 2021-05-06 | $675.00K derived: sum of 2 quarters · filed 2023-06-23 | $889.00K derived: sum of 3 quarters · filed 2023-06-23 | $1.11M derived: sum of 4 quarters · filed 2023-06-23 |
| 2019-12-31 | $108.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-06-23 | $322.00K derived: sum of 2 quarters · filed 2023-06-23 | $543.00K derived: sum of 3 quarters · filed 2023-06-23 | $853.00K 10-K/A · filed 2023-06-23 |
| 2019-09-30 | $214.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $435.00K derived: sum of 2 quarters · filed 2020-11-10 | $745.00K 10-Q · filed 2020-11-10 | $4.21M derived: sum of 4 quarters · filed 2020-11-10 |
| 2019-06-30 | $221.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | $531.00K 10-Q · filed 2020-08-11 | $4.00M derived: sum of 3 quarters · filed 2020-08-11 | $4.92M derived: sum of 4 quarters · filed 2020-08-11 |
| 2019-03-31 | $310.00K 10-Q · filed 2020-05-13 | $3.78M derived: sum of 2 quarters · filed 2020-05-13 | $4.70M derived: sum of 3 quarters · filed 2020-05-13 | |
| 2018-12-31 | $3.47M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | $4.39M derived: sum of 2 quarters · filed 2020-03-05 | $8.98M 10-K · filed 2020-03-05 | |
| 2018-09-30 | $926.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $5.51M 10-Q · filed 2019-11-14 | ||
| 2018-06-30 | $4.59M 10-Q · filed 2019-08-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |